Minimally Invasive, Maximally Effective: The Power of Precision Cytoanalysis on Effusion Samples?A Comprehensive Exploration from Traditional Methods to Innovative Approaches

Autores da FMUP

• 

  Fernando Carlos De Landér Schmitt

  Autor

Participantes de fora da FMUP

• Souza da Silva, R

Unidades de investigação

• Laboratório Associado RISE- Rede de Investigação em Saúde

  

  Investigador

  Fernando Carlos De Landér Schmitt

• Patologia

• RISE-Health

  

  Investigador

  Fernando Carlos De Landér Schmitt

Abstract

[No abstract available]

Copyright © 2024 Elsevier Inc. All rights reserved.

Keywords

• Ascitic Fluid; Biomarkers, Tumor; Cytodiagnosis; Humans; Neoplasms; Pleural Effusion, Malignant; Precision Medicine; cell free DNA; cell free nucleic acid; programmed death 1 ligand 1; unclassified drug; tumor marker; artificial intelligence; breast cancer; cancer classification; cancer diagnosis; cancer growth; cancer immunotherapy; cancer prognosis; cost effectiveness analysis; cytodiagnosis; cytopathology; DNA probe; early diagnosis; effusion; effusion cytology; fluorescence in situ hybridization; gene mutation; genetic analysis; genotyping; high throughput sequencing; human; immunocytodiagnosis; immunohistochemistry; lung cancer; malignant mesothelioma; malignant pleura effusion; minimally invasive procedure; molecular diagnosis; patient monitoring; pericardial effusion; peritoneal effusion; personalized medicine; polymerase chain reaction; precision cytopathology; protein expression; Review; sensitivity and specificity; supernatant; theranostic nanomedicine; tissue fixation; treat